Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)

NCT02003573 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG: decitabine iv
DRUG: volasertib iv infusion

Sponsor

Boehringer Ingelheim